Clinical Trial: Efficacy of Verciguat in TR and RV Failure

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668739) titled 'Efficacy of Verciguat in TR and RV Failure' on June 08.

Brief Summary: The goal of this clinical trial is to learn if the drug vericiguat works to improve right heart function in patients with worsening heart failure who have reduced left ventricular function. It will also examine the effects of the drug on tricuspid regurgitation (TR) and overall clinical outcomes.

The main questions it aims to answer are:

Does vericiguat improve right ventricular (RV) function and reduce tricuspid regurgitation (TR)? Does vericiguat reduce the risk of major adverse cardiovascular events (MACE), such as heart failure hospitalizations and cardiova...